Nitazoxanide
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1065 publications
Chronic persistent Norovirus in the immune-compromised host.
Journal: Current opinion in infectious diseases
Published: March 13, 2026
Conserved use of tetraspanin CD9 as an entry receptor by rhabdoviruses spanning multiple genera.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 11, 2026
Chronic norovirus infection in a patient with Good's syndrome resolved after fecal microbiota transplantion and improved nutrional status.
Journal: Infectious diseases (London, England)
Published: February 13, 2026
Promising Drug Repurposing Candidates Targeting Free-Living Amoebae: A Systematic and Critical Review of Laboratory-Based Evidence.
Journal: Pathogens (Basel, Switzerland)
Published: February 13, 2026
Nitazoxanide-Gold Nanoparticles Combat Carbapenem-Resistant Enterobacteriaceae via Membrane Disruption and Oxidative Stress.
Journal: ACS infectious diseases
Published: February 08, 2026
Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathy.
Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathy.
Journal: The Cochrane database of systematic reviews
Published: February 03, 2026
Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.
Journal: Antiviral research
Published: January 27, 2026
Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 03, 2026
Kaempferol activity on Cryptosporidium parvum infection in an experimentally infected immunocompromised mouse model: In silico and in vivo investigations.
Journal: Pharmaceutical biology
Published: December 19, 2025
Last Updated: 04/28/2026